Flumethasone 21-pivalate
Modify Date: 2025-08-23 08:12:22
Flumethasone 21-pivalate structure
|
Common Name | Flumethasone 21-pivalate | ||
|---|---|---|---|---|
| CAS Number | 2002-29-1 | Molecular Weight | 494.56800 | |
| Density | 1.27g/cm3 | Boiling Point | 600.3ºC at 760mmHg | |
| Molecular Formula | C27H36F2O6 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 316.8ºC | |
| Symbol |
GHS08 |
Signal Word | Warning | |
Use of Flumethasone 21-pivalateFlumethasone pivalate is a glucocorticoid corticosteroid and a corticosteroid ester. Flumetasone pivalate has anti-inflammatory, antipruritic, and vasoconstrictive activities[1]. |
| Name | flumethasone pivalate |
|---|---|
| Synonym | More Synonyms |
| Description | Flumethasone pivalate is a glucocorticoid corticosteroid and a corticosteroid ester. Flumetasone pivalate has anti-inflammatory, antipruritic, and vasoconstrictive activities[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.27g/cm3 |
|---|---|
| Boiling Point | 600.3ºC at 760mmHg |
| Molecular Formula | C27H36F2O6 |
| Molecular Weight | 494.56800 |
| Flash Point | 316.8ºC |
| Exact Mass | 494.24800 |
| PSA | 100.90000 |
| LogP | 3.44070 |
| Vapour Pressure | 6.51E-17mmHg at 25°C |
| Index of Refraction | 1.55 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H351 |
| Precautionary Statements | P280 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R40 |
| Safety Phrases | S22-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TU3832010 |
| Precursor 0 | |
|---|---|
| DownStream 1 | |
CAS#:2135-17-3|
Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation.
Int. J. Pharm. 370(1-2) , 181-6, (2009) Charged drug delivery systems are interesting candidates for the delivery of drugs through skin. In the present study, it was possible to create negatively and positively charged oil/water nanoemulsio... |
|
|
[Darkness effect in photochemotherapy. I. Effect of 8-methoxypsoralen on the epidermal patch test in allergic contact eczema].
Dermatol. Monatsschr. 169(1) , 46-8, (1983)
|
|
|
[Double-blind comparison of a betamethasone dipropionate-iodochloroxyquinoline combination and a flumethasone pivalate-iodochloroxyquinoline combination in the therapy of steroid-sensitive dermatoses with superinfection].
G. Ital. Dermatol. Venereol. 121(1) , XI-XIV, (1986)
|
| MFCD00079287 |
| Flumethasone pivalate |
| Flumethasone 21-Pivalate |
| [2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate |
| EINECS 217-901-1 |